12/3/2024

Janusmed fosterpåverkan

Janusmed fosterpåverkan – Primperan 10

Janusmed fosterpåverkan tillhandahåller bedömningar av eventuella risker för fostret, när en gravid kvinna använder olika läkemedel. Observera att texterna är generella, och att en bedömning måste göras i varje enskilt fall. Om du inte är medicinskt utbildad, läs först vår information för patienter och allmänhet.

För att komma till startsidan för Janusmed fosterpåverkan och för att göra sökningar klicka här.

Tillbaka till index
2 2
2 2

Metoklopramid

Metoklopramid

Klass : 2

Visa all info

Skriv ut

Kontakta oss

  1. Asker C, Norstedt Wikner B, Källén B. Use of antiemetic drugs during pregnancy in Sweden. Eur J Clin Pharmacol 2005;61:899-906.

  2. Berkovitch M, Mazzota P, Greenberg R, Elbirt D, Addis A, Schuler-Faccini L et al. Metoclopramide for nausea and vomiting of pregnancy: a prospective multicenter international study. Am J Perinatol. 2002;19:311-6.

  3. Sun L, Xi Y, Wen X, Zou W. Use of metoclopramide in the first trimester and risk of major congenital malformations: A systematic review and meta-analysis. PLoS One. 2021;16(9):e0257584.

  4. Ishikawa T, Obara T, Akazawa M, Noda A, Oyanagi G, Morishita K et al. Risk of major congenital malformations associated with first-trimester exposure to propulsives: A health administrative database study in Japan. Pharmacoepidemiol Drug Saf. 2021;0(0):0.

  5. Antipsychotic drug labels updated on use during pregnancy and risk of abnormal muscle movements and withdrawal symptoms in newborns. FDA Safety Communication 2011-02-22. goo.gl/ZUzLmH [cited 2014-04-25].

  6. Pharmacovigilance Working Party (PhVWP). Antipsychotics – Risk of extrapyramidal effects and withdrawal symptoms in newborns after exposure during pregnancy. European Medicines Agency. http://goo.gl/rhEKu [cited 2014-04-25].

  1. Asker C, Norstedt Wikner B, Källén B. Use of antiemetic drugs during pregnancy in Sweden. Eur J Clin Pharmacol 2005;61:899-906.
  2. Berkovitch M, Mazzota P, Greenberg R, Elbirt D, Addis A, Schuler-Faccini L et al. Metoclopramide for nausea and vomiting of pregnancy: a prospective multicenter international study. Am J Perinatol. 2002;19:311-6.
  3. Sun L, Xi Y, Wen X, Zou W. Use of metoclopramide in the first trimester and risk of major congenital malformations: A systematic review and meta-analysis. PLoS One. 2021;16(9):e0257584.
  4. Ishikawa T, Obara T, Akazawa M, Noda A, Oyanagi G, Morishita K et al. Risk of major congenital malformations associated with first-trimester exposure to propulsives: A health administrative database study in Japan. Pharmacoepidemiol Drug Saf. 2021;0(0):0.
  5. Antipsychotic drug labels updated on use during pregnancy and risk of abnormal muscle movements and withdrawal symptoms in newborns. FDA Safety Communication 2011-02-22. goo.gl/ZUzLmH [cited 2014-04-25].
  6. Pharmacovigilance Working Party (PhVWP). Antipsychotics – Risk of extrapyramidal effects and withdrawal symptoms in newborns after exposure during pregnancy. European Medicines Agency. http://goo.gl/rhEKu [cited 2014-04-25].